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Abstract
Background: Urinary tract infections (UTI) are frequent in outpatients. Fast pathogen identification is mandatory for
shortening the time of discomfort and preventing serious complications. Urine culture needs up to 48 hours until pathogen
identification. Consequently, the initial antibiotic regimen is empirical.
Aim: To evaluate the feasibility of qualitative urine pathogen identification by a commercially available real-time PCR blood
pathogen test (SeptiFastH) and to compare the results with dipslide and microbiological culture.
Design of study: Pilot study with prospectively collected urine samples.
Setting: University hospital.
Methods: 82 prospectively collected urine samples from 81 patients with suspected UTI were included. Dipslide urine
culture was followed by microbiological pathogen identification in dipslide positive samples. In parallel, qualitative DNA
based pathogen identification (SeptiFastH) was performed in all samples.
Results: 61 samples were SeptiFastH positive, whereas 67 samples were dipslide culture positive. The inter-methodological
concordance of positive and negative findings in the gram+, gram- and fungi sector was 371/410 (90%), 477/492 (97%) and
238/246 (97%), respectively. Sensitivity and specificity of the SeptiFastH test for the detection of an infection was 0.82 and
0.60, respectively. SeptiFastH pathogen identifications were available at least 43 hours prior to culture results.
Conclusion: The SeptiFastH platform identified bacterial DNA in urine specimens considerably faster compared to
conventional culture. For UTI diagnosis sensitivity and specificity is limited by its present qualitative setup which does not
allow pathogen quantification. Future quantitative assays may hold promise for PCR based UTI pathogen identification as a
supplementation of conventional culture methods.
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Introduction
The initial treatment of urinary tract infections (UTI) is mostly
empirical. The immediately started therapy targets to avoid serious
complications such as UTI triggered urosepsis and shortening the
time of patients’ discomfort. The diagnosis of UTI is based on
three criteria: i) Clinical symptoms ii) Detection of signs of
infection in the urine iii) Detection and identification of bacteria in
the urine. The gold standard for pathogen identification is the
urine culture by plated midstream urine [1]. The time need for
preliminary results of the urine culture is at least 24 hours and
final results are commonly available after 48 hours [2].
To date, molecular biology techniques such as real-time PCR
are used to complement conventional culture methods, especially
with regard to shortening the time to result [3,4]. In the diagnosis
of UTI applied real-time PCR methods are presently limited to
the detection of single pathogens or the Gram status [5,6].
Recently, we showed the principle feasibility of UTI pathogen
identification by an in-house developed real-time PCR as a
supplement for culture methods [7]. The main advantage in the
use of real-time PCR techniques is the considerable saving of
time.
A new multiplex real-time PCR test for the detection of 25
common blood stream pathogens (SeptiFastH, Roche Diagnos-
tics GmbH, Penzberg, Germany) has been introduced recently
[4]. An overlap of probe binding sites leads to the final
discrimination of 20 common blood pathogens. The aim of this
prospective pilot study was to investigate the feasibility of the
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quantitative detection and identification of urine pathogens in
UTI patients by the commercially available SeptiFastH test.
Moreover, the SeptiFastH results were compared with the
findings of the conventional dipslide based pathogen detection
and the results of the in-house PCR method. Although there is
an overlap in the panels of frequent of UTI and blood stream
infection pathogens it has to be pointed out that the SeptiFastH
panel was not developed or modified to detect UTI pathogens.
Subsequently, there are relevant UTI pathogens such as
Citrobacter which are not represented in this panel [8].
Methods
Patient cohort
The study was approved by the ethics committee of the
medical faculty of the Rheinische Friedrich-Wilhels-University
Bonn and complied with all relevant guidelines. The inclusion
criteria were: Urological patients with age $18 years, suspected
UTI, absence of enterovesical fistulas, and written informed
consent. Patients with age ,18 years, without written informed
consent, enterovesical fistulas, urinary diversion or bladder
augmentation were excluded. The routine course in case of
suspected UTI consisted of: i) Physical examination by fellows
or consultants of the Department of Urology. ii) Semi
quantitative urine analysis by commercially available urine
dipsticks (Combur-TestH, Roche Diagnostics, Mannheim,
Germany) applied according to the manufacturer’s recommen-
dations. iii) Identification of pathogens by dipslide based
culture method (Dip-Slide Cled/MacConkey/malt extract
agarH, Oxoid, Wesel, Germany) applied according to the
manufacturer’s recommendations and subsequent microbiolog-
ical pathogen identification. The arrangement of the samples is
visualized in figure 1. Microbiological culture data of the
patients were partially included in a previous report [7]. In 82
samples we compared the SeptiFastH results with the previously
published results detected with a in-house real-time PCR
method [7].
Urine sample preparation and conventional urine
analysis
Urine sampling was performed according to local hospital
guidelines for preventing artificial contamination. A sterile
specimen holder with Cled-, MacConkey-agar, and malt extract
agar (Dip-Slide Cled/MacConkey/malt extract agar, Oxoid,
Wesel, Germany) was dunked in the urine sample and cultured
for 24 hours at 36uC. In case of visible bacterial growth the sample
was transferred to the Institute of Microbiology for pathogen
identification. Analysis was done according to standards of the
German Society of Medical Microbiology and Hygiene and the
local hospital guidelines. A sample was regarded as a true positive
infection when .105 CFU/ml urine were detected [9–11].
PCR sample preparation and PCR procedure
A 10ml midstream urine sample for PCR diagnostic was
transferred on ice to the PCR laboratory. For complete
accordance to the SeptiFastH test guidelines the preparation of
DNA and PCR testing was performed from 1 ml urine using the
PCR Lysis Kit, the SeptiFastH Prep Kit and the LightCycler
SeptiFastH Kit as described recently [4]. In brief, samples were
mechanically lyzed and internal controls (IC) were included in
each sample and in negative controls (NC). Manual extraction was
performed to obtain a final extraction volume of 200 ml DNA.
50 ml of eluate were used for the subsequent real-time PCR
amplification using the LightCycler 2.0 Instrument. Potential
process contaminations were eliminated using uracil-N-glycosy-
lase. DNA amplification targets conserved and variable parts of
the internal transcribed sequence regions of bacteria and fungi [4].
Amplified variable parts of any amplification products were then
hybridized to genus- or species-specific oligonucleotide probes and
subjected to software-assisted temperature melting-peak (Tm)
analysis using the Bacterial and Fungal Identification Software
Package Version 3.0.4.28 (Roche Diagnostics GmbH, Penzberg,
Germany) to reliably identify microorganisms. The SeptiFastH
pathogen panel is displayed in table 1. SeptiFastH results were
regarded as true negative only if included IC’s are measured
Figure 1. Workflow of the urine specimens to the different tests. Samples were classified as positive and count as one in case of mono or
multiple infection.
doi:10.1371/journal.pone.0017146.g001
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positive. Moreover, the assay was regarded valid only if the NC
tested negative and the corresponding controls (reagent control
and the IC of the NC) were detected within their assigned Tm
ranges. According to recent study data time to report for the
method’s workflow is less than four hours and the analytical
sensitivity of the assay ranges between 3 and 100 CFU/ml in
whole blood depending on the individual microorganism [4].
Presently, no data concerning the analytical sensitivity in urine are
available by the manufacturer.
Statistical Methods
For the calculation of sensitivity and specificity of SeptiFastH test
the microbiological culture and identification method was
considered as the gold standard method. The comparison of both
methods was performed by the calculation of the positive and
negative predictive value and Cohen’s kappa coefficient. On
pathogen level the species specific overall concordance was
calculated as the ratio of the sum of positive and negative identical
results to the entire number of results. For the analysis of mono- or
polymicrobial infections concordance was calculated as the sum of
positive identical results to the entire number of results.
Results
81 patients were enrolled in the study. One patient suffered
from two consecutive UTI episodes which resulted in 82 samples
from 81 patients. Table 2 shows the baseline characteristics of the
patient group. Initial dipslide culture results were available
24 hours after specimen collection. Subsequent conventional
pathogen identification for positive dipslide samples required
additional 24 hours. In contrast, PCR results were available
4.5 hours after specimen collection. Of note, results of this pilot
study were not used for therapeutic decisions.
Real-time PCR detected 61 infections and 21 infection-negative
samples, whereas, culture method identified 67 infections and 15
infection-negative results. Table 3 shows the distribution of
positive and negative results obtained with both methods.
Citrobacter species was identified in four samples by culture based
methods as a co-pathogen in multiple infected samples. Since this
pathogen is not part of the SeptiFastH detection panel it was
excluded from concordance analysis. This resulted in a sensitivity
of 0.82 and a specificity of 0.60 for the detection of an infection by
the SeptiFastH test in this pilot study. The overall Cohen’s kappa
coefficient is 0.364 and the positive and negative predictive values
are 0.9 and 0.43, respectively. The concordant positive and negative
findings (overall concordance) of the two methods were calculated
on group level as well as on species specific level. Table 4 shows
the results of the gram positive pathogens. In this group lowest
concordance was observed for Coagulase-negative staphylococci iden-
tification 65/82 (79%), whereas, highest concordance was
calculated for Streptococcus pneumoniae 81/82 (99%). The overall
concordance was 371/410 (90%). In the gram negative group
(table 5) the pathogen concordance ranged between 77/82 (94%)
and 81/82 (99%) with lowest concordance for Escherichia coli and
an overall concordance of 477/492 (97%). Finally, in the fungi
group (table 6) the overall concordance was 238/246 (97%) and
varied between 75/82 (91%) and reached 82/82 (100%) for
Candida crusei. Of note, in this group including the pathogens
Candida albicans, Candida glabrata, and Candida crusei only 11
pathogens were detected in total. The limited concordance in
the gram positive group is based on 15 Coagulase-negative staphylococci
and Streptococcus species pathogens identified exclusively by culture
method.
The concordant positive pathogen detections in monoinfections
were 33/43 (77%) separated in 7/14 (50%), 25/28 (89%) and 1/2
(50%) in Gram positive, Gram negative and funghi, respectively.
The overall concordance within the group of polymicrobial
infections was 23/47 (49%). In this group Gram positive, Gram
negative and funghi showed concordance in 9/27 (33%), 14/20
(70%) and 2/3 (67%) of the pathogen detections, respectively.
Finally, we compared the SeptiFastH results with results from a
previously performed in-house PCR of the same collective [7].
Table 7 shows the pathogen detection in 82 samples conducted
with the SeptiFastH method and the in-house method. 51 positive
results showed concordant findings between SeptiFastH and the in-
house method.
Table 1. Pathogens included in the SeptiFastH detection panel.
Gram positive Gram negative Fungi
Staphylococcus aureus Escherichia coli Candida albicans
Coagulase negative staphylococci Klebsiella pneumonia Candida tropicana
Streptococcus pneumoniae Serratia marcescens Candida parapsilosis
Streptococcus spp. Enterobacter Candida krusei
Enterococcus faecium Proteus mirabilis Candida glabrata
Enterococcus faecalis Pseudomonas aeruginosa Aspergillus fumigatus
Acinetobacter baumanii
Stenotrophomonas maltophilia
doi:10.1371/journal.pone.0017146.t001
Table 2. Patient’s baseline characteristics.
Number Percent (%)
Patients 81
Samples 82
Female 43/81 53
Male 38/81 47
Mean Age (range) 49 (18–79)
Clinical entity
- Lower urinary tract infections 39/82 48
- Pyelonephritis 33/82 40
- Obstructive pyelonephritis 10/82 12
doi:10.1371/journal.pone.0017146.t002
PCR Pathogen Identification
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Discussion
Summary of main findings
The presented data indicate for the first time, that the real-time
PCR based SeptiFastH system is applicable in principle for the
qualitative identification of urinary tract pathogens. The time
saving of the PCR based results is about 43 hours compared to the
culture based pathogen identification. Compared to the gold
standard method sensitivity and specificity of the real-time PCR
method was 0.82 and 0.60, respectively, even though this study
was designed as the proof of feasibility and not as a presentation of
a ready to use method.
Strengths and limitations of the study
This pilot study shows that PCR methods might supplement
urine culture based pathogen identifications in the future. The
most important benefit is the faster pathogen identification which
allows an earlier selective antimicrobial therapy. In this first study
the authors decided to deploy the SeptiFastH blood pathogen test
in full accordance to its instruction to answer the question whether
it is feasible in urine samples. In addition, the study was not
designed to analyse the pathogen detection limit of UTI pathogens
in urine. Therefore, the existing blood culture data might be seen
as a substututional reference point of the analytical sensitivity. In
summary, the real-time PCR method was used off-label in urine.
The most important difference between the blood and the urine
compartment in the diagnosis of pathogens is the need for
quantification in UTI diagnosis. In contrast, the qualitative
detection of pathogens is sufficient for the diagnosis of blood
stream infections.
The overall kappa coefficient indicated a very limited
concordance between the two methods as well in the analysis of
gram positive and gram negative bacteria and fungi. Moreover,
the positive and negative predictive values in the different groups
showed variable proportions of correctly diagnosed patients,
respectively pathogens. However, this investigation was designed
as a test of the methodological feasibility and not as the rating of a
new method against the Goldstandard.
Coagulase-negative staphylococci and Streptococcus spp. were frequently
detected by the culture method exclusively, which contributed to
the SeptiFastH sensitivity of 0.82. When turning off the
manufacturer’s given filter for these two pathogens they were
detected by real-time PCR in further 35 samples. With the filter
engaged these signals were not assessed as positive findings,
because the PCR crossing points were too high and exceeded the
SeptiFastH detection window constituted for blood stream
infections. This filter was implemented in the SeptiFastH system
for the reduction of false positive results due to contamination with
cutaneous pathogens in the blood infection setting. It is important
to mention that this filter is not validated for the detection of UTI
pathogens in urine specimens. In the presented research setting a
manual inspection of each PCR crossing point is feasible.
However, prior to the potential future use of real-time PCR
based tests the validation of a cut off value to discriminate infection
from contamination is mandatory. It could be speculated that a
modification of this implemented filter might increase the
Table 3. Detection of infections in 82 samples.
Microbiological culture (n=82 samples)
Positive infection Negative infection g
Real-time PCR SeptiFastH test
(n = 82 samples)
Positive infection 55 6 61
Negative infection 12 9 21
g 67 15 82
Kappa coefficient 0.364
Positive predictive value 0.90
Negative predictive value 0.43
doi:10.1371/journal.pone.0017146.t003
Table 4. Gram positive pathogens.
Exclusively
Microbiology positive
Exclusively
SeptiFastH positive
Microbiology and
SeptiFastH positive
Microbiology and
SeptiFastH negative Concordance [%]
Coagulase-negative
staphylococci
14 3 7 58 65/82 [79]
Staphylococcus aureus 1 2 2 77 79/82 [96]
Streptococcus pneumoniae 0 1 0 81 81/82 [99]
Streptococcus spp 6 2 1 73 74/82 [90]
Enterococcus spp. 4 6 6 66 72/82 [88]
Overall 25 14 16 355 371/410 [90]
Kappa coefficient 0.4
Positive predictive value 0.53
Negative predictive value 0.93
doi:10.1371/journal.pone.0017146.t004
PCR Pathogen Identification
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sensitivity by higher numbers of detected coagulase-negative staphy-
lococci and Streptococcus spp.
An alternative method for pathogen concentration and
subsequent increase of PCR sensitivity is the urine centrifugation
prior to analysis. However, there was no concentration step in this
study. It can be argued that this step might be beneficial to
increase the overall sensitivity of this study.
The most striking results responsible for the limited level of
specificity were 5 samples with exclusively SeptiFastH positive
Candida albicans and 10 samples with exclusively SeptiFastH positive
Enterococcus detection. Additionally, the cut off value applied in
urine culture method detecting UTI is strongly suspicious to
contribute considerably to the reported specificity of 0.60.
Furthermore, the real-time PCR detection is limited by the fact
that pathogens which are not included in the panel are
undetectable and the number of included pathogens is restricted.
In the present investigation four PCR undetected Citrobacter species
findings, which are not included in the panel, demonstrated this
limitation. However, the 8 most frequent outpatient UTI
pathogens are included in the used SeptiFastH panel [8,12,13].
Finally, there is the possibility to detect DNA of vital or
degraded pathogens by real-time PCR in the urine of the patients.
In the case of positive PCR finding but missing clinical UTI signs
the relevance of the detected DNA is unclear. In this situation
degraded DNA might just address a passed or subclinical infection.
Up to now, the clearance of bacterial DNA from the urine is
unclear. Moreover, evidence exists that a filtration of circulating
DNA via the kidney is possible [14]. The contribution of this
filtrated DNA to the total content of bacterial DNA in the urine
remains to be established.
Comparison with existing literature
The use of microbiological culture method is well established in
the diagnosis of infectious diseases. However, the major drawback
is the time consumption of this method. Therefore, initial
antibiotic therapy in blood stream infections as well as in urinary
tract infections is mostly empirical. Several investigations showed
the disadvantages of delayed or inappropriate antimicrobial
therapy, such as decreased survival rate in sepsis, or development
of pathogen resistances [15–19]. Besides these serious complica-
tions, inappropriate UTI therapy extend patients time of
discomfort.
In the field of blood stream infections real-time PCR based
methods as SeptiFastH were engineered to supplement culture
based methods of pathogen identification and to reduce the time
interval of calculated anti-infective therapies. In contrast to the
qualitative PCR pathogen detection in blood stream infections,
quantification is mandatory in the diagnosis of UTI to discrim-
inate contamination from infection. The initial amount of
pathogen DNA is determinable by the assessment of the PCR
crossing point [20,21]. Schabereiter-Gurtner and co workers
reported for Neisseria gonorrhoeae real-time PCR sensitivity about 3
CFU [22]. Other groups reported the lower detection limit of real-
time PCR be about 1 CFU per ml fluid or g tissue [23–25].
Table 5. Gram negative pathogens.
Exclusively
Microbiology positive
Exclusively
SeptiFastH positive
Microbiology and
SeptiFastH positive
Microbiology and
SeptiFastH negative Concordance [%]
Escherichia coli 4 1 32 45 77/82 [94]
Klebsiella pneumonia 2 0 6 74 80/82 [98]
Serratia marcescens 0 1 0 81 81/82 [99]
Enterobacter 1 2 0 79 79/82 [96]
Proteus mirabilis 2 0 0 80 80/82 [98]
Pseudomonas aeruginosa 0 2 1 79 80/82 [98]
Overall 9 6 39 438 477/492 [97]
Kappa coefficient 0.82
Positive predictive value 0.87
Negative predictive value 0.98
doi:10.1371/journal.pone.0017146.t005
Table 6. Fungi.
Exclusively Microbiology
positive
Exclusively SeptiFastH
positive
Microbiology and
SeptiFastH positive
Microbiology and
SeptiFastH negative Concordance [%]
Candida albicans 2 5 2 73 75/82 [91]
Candida glabrata 0 1 0 81 81/82 [99]
Candida crusei 0 0 1 81 82/82 [100]
Overall 2 6 3 235 238/246 [97]
Kappa coefficient 0.41
Positive predictive value 0.33
Negative predictive value 0.99
doi:10.1371/journal.pone.0017146.t006
PCR Pathogen Identification
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Consequently, future developments of commercial real-time PCR
pathogen detection tools should include a quantification option.
The applied dipslide cultures were analysed by experienced
urologic staff after 24 hour incubation. In case of visible growth
microbiological routine diagnostic identified the pathogen
48 hours after specimen collection. This setup was chosen to fully
comply with local hospital guidelines for routine UTI diagnosis.
This might limit the study as plated midstream urine is commonly
seen as the gold standard in urine culture diagnostics [1]. A further
difference between the two methods is that culture methods
exclusively detect viable and reproductive organisms, whereas
PCR detect vital or dead pathogens as well as DNA fragments
from degraded pathogens. Especially this fact might be useful in
the monitoring of infections under antibiotic treatment. Such real-
time PCR based diagnosis and disease monitoring tools are
components of present treatment strategies in patients with viral
infections [26–28].
To date, the acquisition of an antibiogram is possible exclusively
by the culture technique. A real-time PCR triggered initial
antibiotic therapy might be insufficient due to undetected
antibiotic resistance. However, the routinely PCR detection of
resistance genes as surrogate parameters for antibiotic resistance is
practicable. Bacterial resistancy tests, such as the mecA-gene in
Staphylococcus aureus and vanA/vanB in Enterococcus species, are today
widely used in clinical routine approaches for characterisation of
resistant strains [29]. Therefore, an expansion of the PCR based
UTI pathogen identification by the detection of resistance genes
might be a perspective to enhance UTI diagnosis as well.
The comparison of the SeptiFastH method with a recently
published in-house real-time PCR method with pathogen specific
detection probes [7] showed concordant pathogen results in about
70% of the positive samples. In both real-time PCR based
methods an adoption to a quantitative approach was not
performed. The detection probes of both PCR methods are
different. Suboptimal template binding of several probes due to the
secondary or tertiary DNA structure might contribute to
intermethodological differences. An important difference between
both methods is that the SeptiFastH approach was designed as a
multiplex PCR reaction. In contrast, the alternative PCR
approach was designed as parallel PCR reactions and each of
them included specific probes for one pathogen. In the view of
practicability the multiplex SeptiFastH method simplifies the
procedure enormously.
Implications for future research or clinical practice
A precondition for the future routine use of this technique is the
quantification of colony forming units for decision making regarding
significant infection, colonization, and contamination. Since real-
time PCR DNA quantification is well established in clinical and
scientific applications further research should model the quantifi-
cation of the colony forming units by initial amount of DNA. The
development of a standardized commercially available PCR based
test for the identification of UTI pathogens and common resistance
genes seems feasible. Of note, the accurate definition of the test
panel is mandatory for its clinical relevance. Potentially, a
differentiation between in-patients and out-patients pathogen panels
is useful. Because of its high technical pre-requisits the method could
be used in departments which are close connected to a
microbiological laboratory which has to be familiar with real-time
PCRmethods. However, the trend to shift the diagnostic tools to the
patients’ bedside is unbowed. The growing use of microbiological
point of care diagnostic is linked to its simplification. As a vision the
development of PCR devices which choose the program and
perform the analysis automatically might be possible. This step
would bring microbiological point of care diagnostic to the general
practitioner and in case of UTI’s possibly more important to
patients in less developed countries. For the short term real-time
PCR methods might supplement the Goldstandard culture
technique in medical centers. The combination with established
culture methods might decrease the fraction of patients initially
treated with inadequate antimicrobial therapy. A potential use of
this PCR method can be seen for patients under antibiotic therapy
due to recurrent UTI’s or patients with nephrostomy under chronic
antibiotic therapy with UTI symptoms. In such cases negative
microbiological cultures are common. One can speculate that real-
time PCR might serve as a useful adjunct.
Table 7. Pathogen detection with SeptiFastH and an in-house PCR method.
Pathogen SeptiFastH positive (n) In-house PCR [4] positive (n) Concordant positive (n)
Coagulase-negative staphylococci 10 14 4
Staphylococcus aureus 4 3 3
Streptococcus pneumoniae 1 n.a.* n.a.*
Streptococcus spp 3 5 1
Enterococcus 12 5 4
Escherichia coli 33 31 30
Klebsiella pneumonia 6 7 6
Serratia marcescens 1 0 0
Enterobacter spp. 2 1 0
Proteus mirabilis 0 1 0
Pseudomonas aeruginosa 3 3 3
Candida albicans 7 n.a.* n.a.*
Candida glabrata 1 n.a.* n.a.*
Candida crusei 1 n.a.* n.a.*
Pathogen negative 21 21 14
*not applicable because not in the detectable panel of the in-house PCR [4].
doi:10.1371/journal.pone.0017146.t007
PCR Pathogen Identification
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